Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
Boniva injection - labeled renal guidance
Product / population
Ibandronate (Boniva Injection), adult IV injection for postmenopausal osteoporosis
Renal method
Creatinine clearance (CrCl), mL/min; use the product-specific calculation
All record notes are retained here, including notes about sources not selected in this review.
BONIVA index name does not establish an oral formulation
The generic BONIVA page retrieved injection content. Only the explicitly identified injection page was imported as new renal guidance; no oral regimen was inferred from the generic-title page.
What to reconcile: Read the route on the source card, not only the directory name. Do not transfer the injection monitoring or administration schedule to tablets.
The original injection-specific source is preserved. The new official oral-tablet source is a separate formulation record, not a correction made inside the injection card.
What to reconcile: Use the formulation selector to inspect the matching product. The generic-title RX page remains on hold.
Do not administer IV Boniva when CrCl is below 30 mL/min. At or above 30, renal impairment does not require a dose change. Measure serum creatinine before every injection. Verify the current injection label before use of this dated FDA source.
RDM73-boniva-official-1 · Source locator: Renal guidance: 2.6 and 5.3
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.
